CLDN18 and hepatocellular carcinoma: Furthermore, CLDN18 was significantly overexpressed in HCC tumor tissues compared to the adjacent non-tumor tissues, which was consistent with PBMC sequencing results and also validated with the immunohistochemical data from human protein profiles.